A multi-hospital analysis of predictors of oral anticoagulation prescriptions for patients with actionable atrial fibrillation who attend the emergency department

References

• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly the framingham study. Arch Intern Med. 1987;147(9)1561–64. doi:10.1001/archinte.1987.00370090041008
   PubMedGoogle Scholar
• Odutayo A, Wong C, Hsiao A, Hopewell S, Altman DG, Emdin CA. l. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. Bmj. 2016:i4482. doi:10.1136/bmj.i4482
   PubMedGoogle Scholar
• Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults. JAMA. 2001;285(18):2370. doi:10.1001/JAMA.285.18.2370
   PubMed Web of Science ®Google Scholar
• Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12)857. doi:10.7326/0003-4819-146-12-200706190-00007
   PubMed Web of Science ®Google Scholar
• Verma A, Cairns JA, Mitchell LB, Macie L, Stiell IG, Gladstone D, et al. 2014 focused update of the canadian cardiovascular society guidelines for the management of atrial fibrillation. Can J Cardiol. 2014;30(10):1114–30. doi:10.1016/j.cjca.2014.08.001
   PubMed Web of Science ®Google Scholar
• Buckingham TA, Hatala R. Anticoagulants for atrial fibrillation: why is the treatment rate so low? Clin Cardiol. 2002;25(10)447–54. doi:10.1002/clc.v25:10
   PubMed Web of Science ®Google Scholar
• Gallagher AM, Rietbrocks S, Plumb J, Van Staa TP. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost. 2008;6(9)1500–06. doi:10.1111/j.1538-7836.2008.03059.x
   PubMed Web of Science ®Google Scholar
• Kalra L, Yu G, Perez I, Lakhani A, Donaldson N. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness. Bmj. 2000;320(7244):1236–39. doi:10.1136/bmj.320.7244.1236
   PubMedGoogle Scholar
• Matchar DB, Samsa GP, Cohen SJ, Oddone EZ, Jurgelski AE. Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial. Am J Med. 2002;113(1)42–51. doi:10.1016/S0002-9343(02)01131-2
   PubMed Web of Science ®Google Scholar
• Winter Y, Wolfram C, Schaeg M, Reese JP, Oertel WH, Dodel R, et al. Evaluation of costs and outcome in cardioembolic stroke or TIA. J Neurol. 2009;256(6):954–63. doi:10.1007/s00415-009-5053-2
   PubMed Web of Science ®Google Scholar
• Petty GW, Brown RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke. 2000;31(5)1062–68. doi:10.1161/01.STR.31.5.1062
   PubMed Web of Science ®Google Scholar
• Macle L, Andrade JG. Evidence-based anticoagulation decision making for atrial fibrillation—how we are doing? (Maybe not so well?). Can J Cardiol. 2016;32(3)278–80. doi:10.1016/j.cjca.2015.06.025
   PubMed Web of Science ®Google Scholar
• Steinberg BA, Kim S, Thomas L, Fonarow GC, Hylek E, Ansell JE, et al. Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry. Circulation. 2014;129(20):2005–12. doi:10.1161/CIRCULATIONAHA.114.008643
   PubMed Web of Science ®Google Scholar
• O’Brien EC, Holmes DN, Ansell JE, Allen LA, Hylek E, Kowey PR, et al. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry. Am Heart J. 2014;167(4):601–09. e1.
   PubMed Web of Science ®Google Scholar
• Coll-Vinent B, Martín A, Malagón F, Suero C, Sanchez J, Varona M, et al. Stroke prophylaxis in atrial fibrillation: searching for management improvement opportunities in the emergency department: the HERMES-AF study. Ann Emerg Med. 2015;65(1):1–12. doi:10.1016/j.annemergmed.2014.07.016
   PubMed Web of Science ®Google Scholar
• Atzema CL, Austin PC, Chong AS, Dorian P. Factors associated with 90-day death after emergency department discharge for atrial fibrillation. Ann Emerg Med. 2013;61(5):539–48. e1.
   PubMed Web of Science ®Google Scholar
• Scheuermeyer FX, Innes G, Pourvali R, Dewitt C, Grafstein E, Heslop C, et al. Missed opportunities for appropriate anticoagulation among emergency department patients with uncomplicated atrial fibrillation or flutter. Ann Emerg Med. 2013;62(6):557–65. e2.
   PubMed Web of Science ®Google Scholar
• Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz M, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955–62. doi:10.1016/S0140-6736(13)62343-0
   PubMed Web of Science ®Google Scholar
• Andò G, Capranzano P. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: a systematic review and network meta-analysis. Int J Cardiol. 2017;15(231)162–69. doi:10.1016/j.ijcard.2016.11.303
   Google Scholar
• Atzema CL, Austin PC, Chong AS, Dorian P, Jackevicius CA. The long-term use of warfarin among atrial fibrillation patients discharged from an emergency department with a warfarin prescription. Ann Emerg Med. 2015;66(4):347– 54. e2.
   PubMed Web of Science ®Google Scholar
• Atzema CL, Yu B, Ivers N, Rochon P, Lee DS, Schull MJ, et al. Incident atrial fibrillation in the emergency department in Ontario: a population-based retrospective cohort study of follow-up care. C Open. 2015;3(2):E182–E191. doi:10.9778/cmajo.20140099
   PubMedGoogle Scholar